Drugmakers pay $67 million to settle claims they exaggerated cancer drug's effectiveness

Genentech and another drugmaker will pay $67 million to settle claims that they misled doctors into prescribing a treatment to lung cancer patients for whom the companies knew it would not work.
Read more: http://www.latimes.com/business/la-fi-genentech-tarceva-settlement-20160607-snap-story.html?source=Snapzu